MWP
KDNY

MYCIO Wealth Partners’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

MYCIO Wealth Partners’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-9
Closed – – 1058
2016
Q2 		$0 Buy
+9
New +$547 ﹤0.01% 1166

Other funds holding KDNY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

MYCIO Wealth Partners's KDNY Position: Q3 2016 in Review

MYCIO Wealth Partners sold out of Chinook Therapeutics, Inc. Common Stock (KDNY) in Q3 2016, closing a stake of 9 shares.

MYCIO Wealth Partners first reported a position in KDNY in Q2 2016 and held it in 1 quarter. The position peaked at $0 in Q2 2016. 93 funds tracked by Wall St. Rank hold KDNY as of Q3 2016.

  • MYCIO Wealth Partners reported no remaining Chinook Therapeutics, Inc. Common Stock position as of Q3 2016 after selling out during the quarter.
  • MYCIO Wealth Partners sold 9 Chinook Therapeutics, Inc. Common Stock shares in Q3 2016.
  • MYCIO Wealth Partners first reported a position in Chinook Therapeutics, Inc. Common Stock in Q2 2016 and held it in 1 quarter.
  • MYCIO Wealth Partners's Chinook Therapeutics, Inc. Common Stock position peaked at $0 in Q2 2016.
  • 93 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q3 2016.

Based on MYCIO Wealth Partners's 13F filing for Q3 2016, filed 3 Nov 2016.